Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Cytoplasmic-bacteriophage-display-system

 Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
OF THE INVENTION The phosphonate internucleosidyl linkages used in oligomers of the present ...


 Sequence specific DNA binding by p53
It is an object of the invention to provide a method for detecting the presence of wild-type p53 ...


 C-pyrazole A.sub.2A receptor agonists
We claim: 1. A composition of matter having the formula: ##STR00032## 2. A method for stimulating ...


 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
Advantageously, the present invention provides E1 expressing cell lines that are stable, can be ...


 Method for investigating the condition of a bacterial suspension through frequency profile of electrical admittance
We claim: 1. A method of investigating the condition of a suspension of bacteria in a fluid medium, ...


 Apparatus and methods for electroporation and electrofusion
To achieve the objects of this invention, a method of electroporation of a first type of cells is ...


 Controlled electroporation and mass transfer across cell membranes
The present invention arises in part from the discovery that the onset and extent of ...


 Antisense oligonucleotide alkylphosphonothioates and arylphospohonothioates
In a first aspect, the invention provides a method for synthesizing oligonucleotides having ...


 Polymer controlled induced viscosity fiber system and uses thereof
OF THE INVENTION As used in this application: a. "glycemic index" (GI) is calculated by dividing ...


 Methods and compositions for expression of competent eukaryotic gene products
DNA constructions are provided comprising control elements derived from heat-shock genes associated ...


 Cytoplasmic bacteriophage display system

Details
Inventors: Studier, F. William; Rosenberg, Alan H.;
Assignee: Associated Universities Inc. (Washington, DC)
Primary Examiner: Achutamurthy; Ponnathapura
Assistant Examiner: Bui; Phuong T.
Attorney, Agent or Firm: Bogosian; Margaret C.

Disclosed are display vectors comprising DNA encoding a portion of a structural protein from a cytoplasmic bacteriophage, joined covalently to a protein or peptide of interest. Exemplified are display vectors wherein the structural protein is the T7 bacteriophage capsid protein. More specifically, in the exemplified display vectors the C-terminal amino acid residue of the portion of the capsid protein is joined to the N-terminal residue of the protein or peptide of interest. The portion of the T7 capsid protein exemplified comprises an N-terminal portion corresponding to form 10B of the T7 capsid protein. The display vectors are useful for high copy number display or lower copy number display (with larger fusion). Compositions of the type described herein are useful in connection with methods for producing a virus displaying a protein or peptide of interest.

DETAILED DESCRIPTION The present invention relates, in one aspect, to a display vector comprising DNA encoding a portion of a structural protein from a cytoplasmic bacteriophage, joined covalently to a protein or peptide of interest.
In preferred embodiments, the structural protein is selected from the group consisting of capsid, tail, tail-fiber and head-tail connector proteins.
Exemplified are display vectors wherein the structural protein is the T7 bacteriophage capsid protein.
More specifically, in the exemplified display vectors the C-terminal amino acid residue of the portion of the capsid protein is joined to the N-terminal residue of the protein or peptide of interest.
The portion of the T7 capsid protein exemplified comprises an N-terminal portion corresponding to form 10B of the T7 capsid protein.
In preferred embodiments in which high copy number display is desired, wild-type T7 capsid protein regulatory signals are employed (e.
g.
, promoter and translation initiation signals).
Other embodiments which are useful for producing larger fusion at a lower copy number on the assembled viral capsid lack wild-type capsid protein promoter and translation initiation signals.
The subject invention also relates to cells containing a display vector of the type described above.
Viral lysates containing assembled cytoplasmic bacteriophage particles bearing fusions to a cytoplasmic structural protein are also encompassed.
Compositions of the type described above are useful in connection with methods for producing a virus displaying a protein or peptide of interest.
In such methods, a virus- based display vector of the type described above is used to clone DNA fragments such that the display vector encodes a fusion protein comprising the portion of the structural protein fused to protein or peptide sequences encoded by the DNA fragments.
Cells are then infected with the virus-based display vector and viral lysates are screened to identify viral particles in which the protein or peptide of interest is expressed as a fusion protein joined to the structural gene from the cytoplasmic bacteriophage



Related patents
  Diagnosis of alzheimer disease stage by mononuclear cell cytokine secretions
AND ADVANTAGES According to the present invention, a method of diagnosing and determining the disease stage or severity of a degenerative disease of the central nervous ...
  Polyvalent display libraries
I. General The present invention is directed to inter alia two related but self-sufficient improvements in conventional display methods. The first improvement provides ...
  Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
OF THE INVENTION A. Definitions Amino Acid Residue: An amino acid formed upon chemical digestion (hydrolysis) of a polypeptide at its peptide linkages. The amino acid ...
  Pharmaceutical and diagnostic business systems and methods
Improved business methods, devices, and systems for utilizing genetic information are provided. According to one embodiment of the invention a business method is ...
  Addition compound of a nucleotide and an amino acid and the use thereof in protection against actinic radiation
I claim: 1. A topical composition for protection against actinic radiation, comprising a dermatologically acceptable inert carrier suitable for application to human skin,...
  Method of differential display of exposed mRNA by RT/PCR
We claim: 1. A method of comparing the presence or level of individual mRNA molecules in two or more nucleic acid samples, comprising the steps of: providing a first ...
  Methods of screening for compounds that derepress or increase telomerase activity
We claim: 1. Method for screening for a telomerase derepression agent, the method comprising the steps of: contacting a cell lacking telomerase activity with a potential ...
  Oral vaccines
What is claimed is: 1. A protein conjugate comprising an immunogen covalently linked to a carrier molecule, wherein said carrier molecule is capable of specifically ...
  Method for identifying validated target and assay combinations for drug development
The invention relates to methods that couple the validation of a target (see Definitions) for drug discovery with the development of an assay to identify compounds that ...
  Synthetic DNA sequences having enhanced expression in monocotyledonous plants and method for preparation thereof
OF THE PREFERRED EMBODIMENTS The following definitions are provided for clarity of the terms used in the description of this invention. "Rare monocotyledonous codons" ...

0.024

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved